Results 91 to 100 of about 545 (126)
Some of the next articles are maybe not open access.
Management of Central Diabetes Insipidus
Best Practice & Research Clinical Endocrinology & Metabolism, 2020The treatment of central diabetes insipidus has not changed significantly in recent decades, and dDAVP and replacement of free water deficit remain the cornerstones of treatment. Oral dDAVP has replaced nasal dDAVP as a more reliable mode of treatment for chronic central diabetes insipidus.
Aoife Garrahy, Christopher J Thompson
exaly +3 more sources
DDAVP in the Treatment of Central Diabetes Insipidus
New England Journal of Medicine, 1976DDAVP, 1-desamino-8-d-arginine-vasopressin, is a synthetic analogue of vasopressin with increased antidiuretic activity and decreased pressor activity. Whereas the antidiuretic-to-pressor ratio of arginine vasopressin is 1, the antidiuretic-to-pressor ratio of DDAVP is 4000.
Alan G. Robinson
exaly +3 more sources
Central Diabetes Insipidus in Children and Young Adults
New England Journal of Medicine, 2000Central diabetes insipidus is rare in children and young adults, and up to 50 percent of cases are idiopathic. The clinical presentation and the long-term course of this disorder are largely undefined.We studied all 79 patients with central diabetes insipidus who were seen at four pediatric endocrinology units between 1970 and 1996.
Maurizio Aricò +2 more
exaly +8 more sources
Neuroimaging of central diabetes insipidus
2021Central diabetes insipidus (CDI) occurs secondary to deficient synthesis or secretion of arginine vasopressin peptide from the hypothalamo-neurohypophyseal system (HNS). It is characterized by polydipsia and polyuria (urine output >30mL/kg/day in adults and >2l/m2/24h in children) of dilute urine (
Terence Patrick, Farrell +2 more
openaire +2 more sources
Neurophysins in Central Diabetes insipidus
Hormone Research, 2008When they were discovered by Acher and co-workers, neurophysins were thought to act as carriers for the active nonapeptides vasopressin (AVP) and oxytocin (OT) and were then recognized as the inactive fragment of a precursor with a higher molecular weight (propressophysin).
J J, Legros, V, Geenen
openaire +2 more sources
The Diagnosis of Children with Central Diabetes Insipidus
Journal of Pediatric Endocrinology and Metabolism, 2007Central diabetes insipidus is the end result of a number of different diseases that affect the hypothalamic-neurohypophyseal system. In many patients, especially children and young adults, it is caused by the destruction or degeneration of neurons that originate in the supraoptic and paraventricular nuclei of the hypothalamus. The known causes of these
GHIRARDELLO S +3 more
openaire +3 more sources
Central and Nephrogenic Diabetes Insipidus: Updates on Diagnosis and Management
Diabetes insipidus (DI) is a rare endocrine disease involving antidiuretic hormone (ADH), encompassing both central and nephrogenic causes. Inability to respond to or produce ADH leads to inability of the kidneys to reabsorb water, resulting in hypotonic
Kathryn Flynn +4 more
exaly +3 more sources

